Compare CDW & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDW | ZBH |
|---|---|---|
| Founded | 1984 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 19.5B |
| IPO Year | 2013 | 2001 |
| Metric | CDW | ZBH |
|---|---|---|
| Price | $119.01 | $93.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 19 |
| Target Price | ★ $164.88 | $105.17 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 2.12% | 1.05% |
| EPS Growth | ★ 1.38 | N/A |
| EPS | ★ 8.08 | 3.55 |
| Revenue | ★ $10,768,600,000.00 | $8,231,500,000.00 |
| Revenue This Year | $4.08 | $4.93 |
| Revenue Next Year | $4.01 | $3.72 |
| P/E Ratio | ★ $14.74 | $25.93 |
| Revenue Growth | 6.32 | ★ 7.20 |
| 52 Week Low | $118.16 | $84.59 |
| 52 Week High | $189.45 | $114.44 |
| Indicator | CDW | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 34.17 | 46.18 |
| Support Level | N/A | $93.29 |
| Resistance Level | $150.48 | $95.33 |
| Average True Range (ATR) | 4.28 | 2.41 |
| MACD | -0.37 | -0.98 |
| Stochastic Oscillator | 14.00 | 26.98 |
CDW Corp is a multi-brand provider of information technology (IT) solutions to businesses, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's offerings range from hardware and software products to integrated IT solutions and services, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Its reportable segments are Corporate, Small Business, Public, and Other. The Corporate and Small Business segments serve US private sector business customers, while the Public segment consists of government agencies and education and healthcare institutions in the US. The Corporate segment generates the majority of its revenue in the United States.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.